Status:
UNKNOWN
Effects of HTEA ON Heart Failure Secondary to Idiopathic Dilated Cardiomyopathy or Post-myocardial Infarction
Lead Sponsor:
Harbin Medical University
Conditions:
Congestive Heart Failure
Eligibility:
All Genders
20-80 years
Brief Summary
The investigators would evaluate the effects of the novel method, HTEA on cardiac function in the heart failure patients secondary to idiopathic dilated cardiomyopathy and post-myocardial infarction.
Detailed Description
The investigators would evaluate the effects of the novel method, HTEA on cardiac function in the heart failure patients secondary to idiopathic dilated cardiomyopathy and post-myocardial infarction. ...
Eligibility Criteria
Inclusion
- 90 chronic cardiac failure patients in our hospital were selected and divided into two groups.
Exclusion
- Vavular diseases
Key Trial Info
Start Date :
May 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2015
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT02292043
Start Date
May 1 2013
End Date
January 1 2015
Last Update
November 17 2014
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Ren Xiaohui
Harbin, Heilongjiang, China, 150001
2
the first affiliated hospital of Harbin Medical University
Harbin, Heilongjiang, China, 150001